# DoW Neurofibromatosis Research Academy – Leadership Award

Source: https://welltoldgrants.com/grants/ht942526nfrpnfrala-dow-neurofibromatosis-research-academy-leadership-award/  
Official notice: https://www.grants.gov/search-results-detail/362917

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make one award worth $2.4 million in total. Applications closed on September 14, 2026.

| Field | Value |
|---|---|
| Opportunity number | HT942526NFRPNFRALA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | September 14, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $2.4 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Leadership Award (NFRALA) supports visionary, established neurofibromatosis (NF) investigators with documented history of neurofibromatosis funding, publications, strong mentorship and commitment to leadership to serve as Director and Deputy Director of the Neurofibromatosis Research Academy. The Academy Director and Deputy Director will execute a multi-institutional, interactive, virtual research academy that consists of scholars, who are early-career investigators, and their career guides, who serve as the scholars’ primary mentors. Distinctive Features: • Academy Director: Established NF investigators at or above the level of Associate Professor, or equivalent, at the full application submission deadline. • Academy Deputy Director: Investigators at or above the level of Associate Professor, or equivalent, at the full application deadline and affiliated with a different institution than the Academy Director. • Pilot Research Project: The Academy Director and Deputy Director will conduct one or more pilot research projects in collaboration with the academy scholars. Preliminary and/or published data relevant to NF and the proposed research project are encouraged but not required.

## Questions people ask

### Is HT942526NFRPNFRALA still open?

No. It closed on September 14, 2026. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoW Neurofibromatosis Research Academy – Leadership Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoW Neurofibromatosis Research Academy – Leadership Award?

Closed September 14, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $2.4 million in total for one award.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.